Long Focus Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Long Focus Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-540,000	Closed	-$2.21M	–	122
2022 Q1	$2.21M	Hold	540,000	–	–	0.28%	56
2021 Q4	$1.93M	Buy	+540,000	New	+$1.89M	0.26%	54

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Long Focus Capital Management's ATRS Position: Q2 2022 in Review

Long Focus Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 540,000 shares — an estimated $2.21M sold.

Long Focus Capital Management first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $2.21M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Long Focus Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Long Focus Capital Management sold 540,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $2.21M.
Long Focus Capital Management first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
Long Focus Capital Management's Antares Pharma, Inc. position peaked at $2.21M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Long Focus Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.